Acorah Software Products - Accounts Production 14.6.300 false true 31 January 2023 1 February 2022 false 1 February 2023 31 January 2024 31 January 2024 10282578 Mr Tabarak Sadik iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10282578 2023-01-31 10282578 2024-01-31 10282578 2023-02-01 2024-01-31 10282578 frs-core:CurrentFinancialInstruments 2024-01-31 10282578 frs-core:Non-currentFinancialInstruments 2024-01-31 10282578 frs-core:ShareCapital 2024-01-31 10282578 frs-core:RetainedEarningsAccumulatedLosses 2024-01-31 10282578 frs-bus:PrivateLimitedCompanyLtd 2023-02-01 2024-01-31 10282578 frs-bus:FilletedAccounts 2023-02-01 2024-01-31 10282578 frs-bus:SmallEntities 2023-02-01 2024-01-31 10282578 frs-bus:AuditExempt-NoAccountantsReport 2023-02-01 2024-01-31 10282578 frs-bus:SmallCompaniesRegimeForAccounts 2023-02-01 2024-01-31 10282578 frs-core:UnlistedNon-exchangeTraded 2024-01-31 10282578 frs-core:UnlistedNon-exchangeTraded 2023-01-31 10282578 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2023-01-31 10282578 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2024-01-31 10282578 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2023-01-31 10282578 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2024-01-31 10282578 frs-bus:Director1 2023-02-01 2024-01-31 10282578 frs-countries:EnglandWales 2023-02-01 2024-01-31 10282578 2022-01-31 10282578 2023-01-31 10282578 2022-02-01 2023-01-31 10282578 frs-core:CurrentFinancialInstruments 2023-01-31 10282578 frs-core:Non-currentFinancialInstruments 2023-01-31 10282578 frs-core:ShareCapital 2023-01-31 10282578 frs-core:RetainedEarningsAccumulatedLosses 2023-01-31
Registered number: 10282578
Vivo Healthcare Limited
Unaudited Financial Statements
For The Year Ended 31 January 2024
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 10282578
2024 2023
Notes £ £ £ £
FIXED ASSETS
Investments 4 1,569,284 1,569,284
1,569,284 1,569,284
CURRENT ASSETS
Cash at bank and in hand 767 123
767 123
Creditors: Amounts Falling Due Within One Year 5 (256,624 ) (246,228 )
NET CURRENT ASSETS (LIABILITIES) (255,857 ) (246,105 )
TOTAL ASSETS LESS CURRENT LIABILITIES 1,313,427 1,323,179
Creditors: Amounts Falling Due After More Than One Year 6 (1,213,327 ) (1,279,977 )
NET ASSETS 100,100 43,202
CAPITAL AND RESERVES
Called up share capital 7 100 100
Profit and Loss Account 100,000 43,102
SHAREHOLDERS' FUNDS 100,100 43,202
Page 1
Page 2
For the year ending 31 January 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Tabarak Sadik
Director
11/10/2024
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Vivo Healthcare Limited is a private company, limited by shares, incorporated in England & Wales, registered number 10282578 . The registered office is 280 East Barnet Road, East Barnet, London, Barnet, EN4 8TD.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
4. Investments
Unlisted
£
Cost
As at 1 February 2023 1,569,284
As at 31 January 2024 1,569,284
Provision
As at 1 February 2023 -
As at 31 January 2024 -
Net Book Value
As at 31 January 2024 1,569,284
As at 1 February 2023 1,569,284
5. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Bank loans and overdrafts 37,001 37,001
Amounts owed to group undertakings 170,228 172,832
Other creditors 49,395 36,395
256,624 246,228
Page 3
Page 4
6. Creditors: Amounts Falling Due After More Than One Year
2024 2023
£ £
Bank loans 413,327 479,977
Other creditors 400,000 400,000
Amounts owed to group undertakings 400,000 400,000
1,213,327 1,279,977
7. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 100 100
Page 4